Evaluation of variables influencing success and complication rates in canine total hip replacement: Results from the British Veterinary Orthopaedic Association Canine Hip Registry (collation of data: 2010-2012)

Publication date 1st April 2017
Authors E R Henderson, A Wills, A M Torrington, A P Moores, D Thomson, G Arthurs, G Brown, H R Denny, H W Scott, I MacQueen, J Dunne, J Onyett, J D Walker, J Prior, M R Owen, N Burton, R Whitelock, Sarah Girling, S Morrison, S Gilbert, S J Langley-Hobbs, T J Gemmill, C K Störk, S Bright, E Comerford, R Pettitt, N Macdonald, J F Innes

Summary

The objective of this study was to assess the variables associated with complications of total hip replacement (THR) and report owner-assessed outcomes. Entries into the British Veterinary Orthopaedic Association-Canine Hip Registry (BVOA-CHR) between September 2011 and December 2012 were reviewed separately and in conjunction with previous data (January 2010-August 2011). An outcomes assessment questionnaire was used to collect data from owners. Incidences of surgeon-reported and owner-reported complications were 8.2 per cent and 4.3 per cent, respectively. THR using the BioMedtrix BFX cup/stem prosthesis had a greater incidence of complications compared with THR using the BioMedtrix CFX cup/stem prosthesis (P=0.002); complications were 4.48 times more likely when using the BioMedtrix BFX cup/stem prosthesis versus the BioMedtrix CFX cup/stem prosthesis. THR using the BioMedtrix BFX cup/stem prosthesis had a higher incidence of complications compared with THR using a hybrid prosthesis (BioMedtrix BFX cup/CFX stem, BioMedtrix CFX cup/BFX stem) (P=0.046); complications were 2.85 times more likely when using the BioMedtrix BFX cup/stem prosthesis versus a hybrid prosthesis. In 95 per cent of cases, owner satisfaction with the outcome of THR was 'very good' or 'good'. Complication rates from the BVOA-CHR are similar to previous studies. The data suggest that prosthesis type is associated with complication rate, with BioMedtrix BFX (circa 2012) having a high short-term complication rate.